EUVIMEDEUVIMED entdecken
Open Access

TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression

Araceli López-Tejada, Carmen Griñán-Lisón, Adrián González-González, Francisca E Cara, Rafael J Luque, Carmen Rosa-Garrido, José L Blaya-Cánovas, Alba Navarro-Ocón, María Valenzuela-Torres, Marisa Parra-López, Jesús Calahorra, Isabel Blancas und 2 weitere

International Journal of Biological Sciences · 2023

DOI: 10.7150/ijbs.78738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2023. Verfasst von Araceli López-Tejada und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology 2, School of Pharmacy, University of Granada, 18011 Granada, Spain. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Transforming Growth Factor beta, Triple Negative Breast Neoplasms, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In triple-negative breast cancer (TNBC), the pleiotropic NDRG1 (N-Myc downstream regulated gene 1) promotes progression and worse survival, yet contradictory results were documented, and the mechanisms remain unknown. Phosphorylation and localization could drive NDRG1 pleiotropy, nonetheless, their role in TNBC progression and clinical outcome was not investigated. We found enhanced p-NDRG1 (Thr346) by TGFβ1 and explored whether it drives NDRG1 pleiotropy and TNBC progression. In tissue microarrays of 81 TNBC patients, we identified that staining and localization of NDRG1 and p-NDRG1 (Thr346) are biomarkers and risk factors associated with shorter overall survival. We found that TGFβ1 leads NDRG1, downstream of GSK3β, and upstream of NF-κB, to differentially regulate migration, invasion, epithelial-mesenchymal transition, tumor initiation, and maintenance of different populations of cancer stem cells (CSCs), depending on the progression stage of tumor cells, and the combination of TGFβ and GSK3β inhibitors impaired CSCs. The present study revealed the striking importance to assess both total NDRG1 and p-NDRG1 (Thr346) positiveness and subcellular localization to evaluate patient prognosis and their stratification. NDRG1 pleiotropy is driven by TGFβ to differentially promote metastasis and/or maintenance of CSCs at different stages of tumor progression, which could be abrogated by the inhibition of TGFβ and GSK3β.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Cycle ProteinsTransforming Growth Factor betaTriple Negative Breast NeoplasmsIntracellular Signaling Peptides and ProteinsHumansCell Line, TumorGene Expression Regulation, NeoplasticGlycogen Synthase Kinase 3 betaNF-kappa BN-myc Downstream-Regulated Gene 1 ProteinTransforming Growth Factor beta1

Stichwörter der Autor:innen

Cancer stem cellNDRG1TGFβTriple-negative breast cancerTumor progression

Substanzen

Cell Cycle ProteinsGlycogen Synthase Kinase 3 betaNF-kappa BTransforming Growth Factor betaIntracellular Signaling Peptides and ProteinsN-myc Downstream-Regulated Gene 1 ProteinTGFB1 protein, humanTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology 2, School of Pharmacy, University of Granada, 18011 Granada, Spain.
  • GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain.
  • Instituto de Investigación Biosanitaria ibs.GRANADA, University Hospitals of Granada-University of Granada, Spain; Conocimiento s/n 18100, Granada. Spain.
  • UGC de Oncología Médica, Hospital Universitario de Jaén, 23007 Jaén, Spain.
  • UGC de Anatomía Patológica, Hospital Universitario de Jaén, Jaén, Spain.
  • FIBAO, Hospital Universitario de Jaén, Servicio Andaluz de Salud, Jaén, Spain.

Zitieren

APA

López-Tejada, A., Griñán-Lisón, C., González-González, A., Cara, F. E., Luque, R. J., Rosa-Garrido, C., Blaya-Cánovas, J. L., Navarro-Ocón, A., Valenzuela-Torres, M., Parra-López, M., Calahorra, J., Blancas, I., Marchal, J. A., & Granados-Principal, S. (2023). TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.78738

Vancouver

López-Tejada A, Griñán-Lisón C, González-González A, Cara FE, Luque RJ, Rosa-Garrido C, et al. TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression. International Journal of Biological Sciences. 2023. doi:10.7150/ijbs.78738

BibTeX
@article{LpezTejada2023,
  author = {López-Tejada, Araceli and Griñán-Lisón, Carmen and González-González, Adrián and Cara, Francisca E and Luque, Rafael J and Rosa-Garrido, Carmen and Blaya-Cánovas, José L and Navarro-Ocón, Alba and Valenzuela-Torres, María and Parra-López, Marisa and Calahorra, Jesús and Blancas, Isabel and Marchal, Juan A and Granados-Principal, Sergio},
  title = {TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression},
  journal = {International Journal of Biological Sciences},
  year = {2023},
  doi = {10.7150/ijbs.78738}
}
Kostenlos starten →